Sanqi Tongshu Jiaonang (三七通舒胶囊)三七通舒胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

三七三醇皂苷是一种在国家药监局注册认定的药品。标注生产企业为成都华神集团股份有限公司制药厂。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂、成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂、成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 三七通舒胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 成都华神集团股份有限公司制药厂.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂, 成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂, 成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 三七通舒胶囊Recorded Chinese name: 三七通舒胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 200mg*12粒200 mg × 12 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 成都华神集团股份有限公司制药厂Chinese legal name: 成都华神集团股份有限公司制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20030109

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20030109

Manufacturer

Chinese legal name: 成都华神集团股份有限公司制药厂 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

200 mg × 12 capsules

中文说明书原文Original Chinese source label

批准文号

国药准字Z20030109

生产企业

成都华神集团股份有限公司制药厂(国产)

功能主治

活血化瘀,活络通脉,改善脑梗塞、脑缺血功能障碍,恢复缺血性脑代谢异常,抗血小板聚集,防止血栓形成,改善微循环,降低全血粘度,增强颈动脉血流量,主要用于心脑血管栓塞性病症,主治中风、半身不遂、口舌歪斜、言语蹇涩、偏身麻木。

用法用量

口服。一次1粒,一日3次,4周为一个疗程。建议划破铝箔(平整的一面),取出胶囊服用。

不良反应

个别患者服药后可出现恶心。

禁忌

孕妇禁用,产妇慎用。脑出血禁用。

注意事项

出血性中风在出血期间忌用,对出血后的瘀血症状要慎用。

贮藏

密闭、遮光,置阴凉干燥处(不超过20℃)。

规格

200mg*12粒

证据Evidence

  • 批准文号: 国药准字Z20030109
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.